SHENZHEN, China, Oct. 22, 2025 /PRNewswire/ — nubia, a global leader in smartphone innovation, introduces the nubia Z80 Ultra. The overseas version of this exceptional smartphone will be officially launched on November 6th. The nubia Z80 Ultra promises users an unparalleled experience and will be available for purchase starting from November 18th.

“Innovation has always been the core of nubia’s brand identity and the driving force behind our progress, creating a versatile smartphone that excels in both photography and gaming.” Ni Fei, President of Nubia Technology Co., Ltd.

Unrivaled Power and Endurance: Performance, Gaming, and Photography

The nubia Z80 Ultra is built for both immersive entertainment and sustained power, driven by the Snapdragon® 8 Elite Gen 5 mobile platform for exceptional performance, seamless multitasking, and high-quality gaming via the REDMAGIC-inspired CUBE Gaming Engine. This experience is visually enhanced by the customized BOE X10 1.5K ultra-clear full-screen display, which maximizes visual clarity for immersive content consumption. Complementing this is a versatile dual focal-length system featuring 5th-generation 35mm and 18mm lenses for capturing stunning photos and videos in any setting. Finally, boasting a powerful 7200 mAh battery, along with 80W wired and 80W wireless charging capabilities (accessible with the original nubia 80W wireless charging kit), ensures users stay connected and powered up throughout the day, eliminating concerns about running out of battery.

Featuring a unique design in black, white, and blue, it offers a personalized touch thanks to its physical button shutter, providing enhanced control when taking photos, while the professional-grade AI imaging model simplifies photography by optimizing settings for different scenarios, making it easier for users to achieve stunning results. The nubia Z80 Ultra is tailored to enhance everyday experiences, whether in photography, entertainment, or performance.

Dual Focal Lengths for Dynamic Mobile Photography with a Full-Screen Display

The nubia Z80 Ultra smartphone revolutionizes mobile photography and display technology with its advanced features designed to enhance the user experience. The device is equipped with a stunning BOE X10 1.5K Under-Display Camera full-screen display, delivering vibrant colors and exceptional clarity for an immersive visual experience, whether streaming videos or browsing photos.

Its 3000Hz instant touch sampling rate ensures lightning-fast response times and precise touch control. With a remarkable brightness of 2000 nits, visibility is guaranteed even in bright sunlight, while the integration of a Synaptics touch chip enhances navigation and interaction accuracy.

The nubia Z80 Ultra empowers users with versatile, professional-grade photography thanks to its 1/1.3-inch Light & Shadow Master 990 sensor, which ensures unparalleled image quality and captures every detail with precision, even in challenging low-light conditions. Designed for versatility, the system features customized 18mm optics for expansive ultra-wide-angle shots, an ultra-clear macro lens for stunning close-ups, and a seamless zoom range from 18mm to 85mm to easily frame any subject. Finally, the inclusion of 21 filters offers endless creative possibilities, allowing users to effortlessly personalize their photography.

Maximum Gameplay: AI Super Frame Stabilization, Long Battery Life, and Upgraded Cooling System

Driven by the powerful Snapdragon® 8 Elite Gen 5 mobile platform, the nubia Z80 Ultra is equipped with an upgraded UFS 4.1 storage and LPDDR5X RAM, designed to optimize gaming performance, ensuring that users can enjoy demanding titles without compromise.

With the advanced CUBE Gaming Engine, derived from the renowned REDMAGIC series, the nubia Z80 Ultra maximizes power efficiency while delivering sustained high-frame-rate gameplay. Gamers will appreciate the device’s support for Super Resolution and Super Frame Rate, delivering stunning visuals at up to 2K resolution, and an impressive 144Hz refresh rate. The incorporation of AI Super Frame Stabilization guarantees smooth graphics even in fast-paced moments, enhancing the all-around gaming experience.

The nubia Z80 Ultra is engineered for endurance and durability, integrating an advanced composite liquid metal and oversized 3D Ice Steel VC cooling system. This technology boosts cooling area coverage by 35% for efficient heat dissipation, ensuring optimal, sustained performance during intense gaming without overheating or excessive power consumption. Furthermore, the phone is built to last with IP68 and IP69 dust and water resistance, and its magnetic NFC smart case provides both seamless connectivity for on-the-go gamers and the option to customize the design to express your unique personality.

Redefining Smartphone Aesthetics: Available in Three Colors, Featuring the New Retro Kit 2.0

The nubia Z80 Ultra embodies “performance aesthetics” with its unique natural curvature and four-sided curved bonding process, ensuring a comfortable and secure grip. The device boasts a robust crystal fiber body, a distinctive luminous red ring around the main camera, and a handy customizable shortcut key, available in black, white, and blue (the collector’s Starry Night Edition). Complementing this design is the newly upgraded Retro Kit 2.0, developed in collaboration with Fotorgear. Crafted from tech nano-leather, titanium-toned aluminum alloy, and premium full-grain leather, the kit provides a superior grip and refined texture. Its custom smart controls, tactile mechanical buttons, and programmable dials optimize the photography workflow from assembly to storage, transforming the act of shooting into a cherished ritual.

The nubia Z80 Ultra stands out as an all-around smartphone for photography enthusiasts who desire professional-grade results at their fingertips. The nubia Z80 Ultra emerges as the premier choice for serious gamers in search of unparalleled performance and reliability. Paired with the Retro Kit 2.0, this exceptional device not only pays homage to classic design but also embodies the spirit of modern innovation. The nubia Z80 Ultra is truly redefining the future of smartphone technology.

Discover More:
For more information on the nubia Z80 Ultra and to explore our full range of innovative devices, please visit the nubia Official Website.

HONG KONG, Oct. 22, 2025 /PRNewswire/ — Fibocom (300638.SZ | 0638.HK), a global leading provider of wireless communication modules and edge AI solutions, commenced trading today on the Main Board of the Hong Kong Stock Exchange (HKEX), making history as the first Chinese wireless communication module company to achieve a dual A+H listing.

The listing ceremony began at 9:30 AM, with Chairman Zhang Tianyu and CEO Ying Lingpeng jointly striking the gong, symbolizing Fibocom’s official launch on the Hong Kong market. Attended by key industry figures, strategic partners, and honored guests, the event celebrated this historic milestone for the company.

Speaking at the ceremony, Chairman Zhang Tianyu emphasized:

” Today’s listing is a milestone and a new beginning. Leveraging this achievement, we will continue to innovate, maintain our leadership in wireless module solutions, expand investments in edge AI and robotics, and grow our global presence, delivering superior products and services while creating greater value for customers. While strengthening the foundation of ‘Connecting Everything,’ we have fully embarked on a strategic upgrade toward ‘Intelligent Connectivity of Everything.’ Looking ahead, Fibocom is committed to deeply embedding AI into every scenario and device, achieving a transformative leap from simple connectivity to intelligent connectivity.”

Fibocom’s listing on HKEX marks a significant milestone in our global growth journey. We will continue expanding our international market presence, deepening collaborations with strategic partners worldwide, and maintaining our leadership in the wireless communication module sector. Harnessing our capabilities in communication, AI, and V2X, we remain committed to delivering innovative products and solutions across diverse industries, solidifying our position as the preferred global partner for module and edge AI solutions.

About Fibocom

Fibocom, founded in 1999, is China’s first wireless communication module company listed on both the A-share and H-share markets (300638.SZ, 0638.HK). As a global leading provider of wireless communication modules and AI solutions, Fibocom leverages wireless communication and artificial intelligence as its core technologies to provide integrated hardware and software solutions that empower industry applications. These solutions accelerate the transformation from “Connect Everything” to “Intelligent Connectivity” across diverse industries.

Fibocom’s one-stop solutions encompass cellular communication, AI, automotive, and GNSS modules, as well as AI toolchains, supporting industry-side and mainstream large model integration, and providing AI Agent, global connectivity, and cloud services, driving the digital intelligence upgrades in industries such as robotics, consumer electronics, low-altitude economy, intelligent transportation, smart retail, and smart energy.

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 22, 2025 /PRNewswire/ — IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today announced that the Blood published the latest results of its independently developed fully human anti-GPRC5D CAR-T cell therapy, RD118, for the treatment of relapsed/refractory multiple myeloma (R/R MM). The study demonstrates that RD118 exhibited significant efficacy and a manageable safety profile in heavily pretreated R/R MM patients, offering new therapeutic hope for the patients with a poor prognosis.

The study entitled ‘Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma’ has been published in Blood. Full text available at: https://doi.org/10.1182/blood.2025030559. This is an open-label, phase 1 dose-escalation and expansion study to evaluate the efficacy and safety of RD118 in the treatment of R/R MM, which was conducted at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (registered as NCT05759793 and NCT05219721).

A total of eighteen patients received RD118 infusion in this study, including 17 with R/R MM and 1 with a history of primary plasma cell leukemia (pPCL) who had relapsed after achieving complete remission. Among the 18 patients, the median age was 59.5 years, and the median line of prior therapies was 5. High-risk features included double-hit cytogenetics (50%), triple-class refractoriness (50%), penta-class refractoriness (22.2%), and prior anti-BCMA CAR-T therapy (38.9%). Following lymphodepletion with fludarabine and cyclophosphamide, patients received a single infusion of RD118 at one of three dose levels (1.0, 2.0, or 3.0×10⁶ cells/kg) during the dose-escalation phase or 2.0×10⁶ cells/kg in the expansion cohort. At a median follow-up of 17.0 months, results show that:

Efficacy: The overall response rate (ORR) was 94.4%, with 72.2% of patients achieving complete response or stringent complete responses (CR/sCR). Among the seven patients who had received prior BCMA-directed CAR T-cell therapy, the ORR was 85.7%, with 5 patients (71.4%) achieving CR/sCR. All three patients with extramedullary disease and the patient with pPCL achieved sCR and remained in remission at last follow-up. The median progression-free survival (PFS) was 18.2 months, with 12-month PFS and overall survival (OS) rates of 82.1% and 93.3%, respectively.

Safety: Cytokine release syndrome (CRS) occurred in 88.9% of patients, primarily grade 1-2. Only one patient developed grade 3 or higher CRS, which rapidly recovered with intensive management. One patient developed grade 3 immune effector cell–associated neurotoxicity (ICANS) which resolved within 72 hours. No cerebellar toxicities or treatment-related deaths were reported

Conclusion：Fully human anti-GPRC5D CAR-T therapy RD118 demonstrated a 94.4% ORR and a median PFS of 18.2 months with a manageable safety profile in heavily over pretreated R/R MM, including patients who relapsed after prior anti-BCMA CAR-T therapy.

Professor Mi Jianqing from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, commented: “Multiple myeloma remains an incurable malignant plasma cell disorder. While anti-BCMA CAR-T therapy has greatly transformed the treatment for relapsed/refractory patients, challenges such as antigen escape often leads to relapse, highlighting the need for novel targets to overcome these limitations. GPRC5D has attracted significant attention due to its high expression, specificity, and independence from BCMA. The current study results have validated its potential: among patients previously treated with anti-BCMA CAR-T therapy, RD118 achieved an 85.7% overall response rate, with 71.4% of patients reaching complete response, demonstrating that GPRC5D is a highly promising novel therapeutic target.”

Professor Chunrui Li from Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, commented: “The innovative design of RD118 is the foundation of its outstanding clinical performance. RD118 is a novel GPRC5D-directed CAR-T that incorporates a fully human nanobody (VHH) as its antigen-binding domain. This design provides distinct advantages over conventional scFv, it is expected to lower immunogenicity, and potentially enhanced persistence, offering a new approach to overcome the safety limitations of existing comparable therapies. Meanwhile, the construct also includes a 4-1BB and a CD3ζsignal domains, which support expansion and sustained anti-tumor activity. Together, these features position RD118 as a highly competitive next-generation CAR-T product.”

Ms. Jinhua Zhang, Founder, Chairwoman and CEO of IASO Bio, remarked: “We are delighted that the remarkable research results of IASO Bio’s independently developed anti-GPRC5D CAR-T product, RD118, for the treatment of R/R MM have been published in the prestigious international journal Blood. This achievement marks another significant milestone for the product following the IND approval from China’s NMPA in June 2024. The treatment landscape for multiple myeloma requires continuous innovation, and GPRC5D, alongside BCMA, are represents a crucial therapeutic target in this field. Developed based on our fully human antibody platform, RD118 is designed to provide a new treatment option for patients. It offers renewed hope particularly for those who have relapsed after prior anti-BCMA CAR-T therapy. This publication will further motivate us to advance the clinical development of RD118, with the goal of delivering this innovative therapy to more patients worldwide.”

About RD118

RD118 is an autologous T-cell immunotherapy product targeting G protein-coupled receptor class C group 5 member D (GPRC5D). It can identify and eliminate malignant tumor cells expressing GPRC5D. GPRC5D is highly expressed on multiple myeloma cells. However, in normal tissues, its expression is limited to plasma cells and hair follicle cells. Such a feature has made GPRC5D a promising safe and effective target for the treatment of multiple myeloma.

The antigen recognition domain of RD118 is developed from IASO Bio’s proprietary fully human single-domain antibody library. It has advantages of high affinity, high specificity, and low immunogenicity. The intracellular domain is a fusion of 4-1BB (CD137) and CD3ζ signaling domains. RD118 has been subjected to extensive development and optimization in terms of antibody screening and structure design. The candidate molecule has demonstrated excellent in vitro cytotoxic activity and in vivo tumor suppression ability. Additionally, it has good expansion capability and persistence in vivo, indicating high development potential.

DUBAI, UAE, Oct. 22, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has announced the launch of its exclusive Fiat-to-Crypto Frenzy, a limited-time event designed for new users. The campaign offers participants the chance to share in a 90,000 USDT prize pool by completing simple onboarding and trading tasks.

Running from October 22, 2025, at 10:00 AM UTC until January 20, 2026, at 10:00 AM UTC, the event highlights Bybit’s fiat-to-crypto capabilities, which provide access to more than 300 digital assets. Through Bybit’s peer-to-peer (P2P) platform, users can seamlessly purchase popular tokens such as USDT, BTC and ETH, along with trending altcoins including DOGE, LAYER and MNT, using local fiat currencies.

The Fiat-to-Crypto Frenzy introduces a task-based participation model, where new users who sign up and complete identity verification can unlock rewards. Tasks include making a minimum deposit of 20 USDT via P2P, Fiat Deposit or One-Click Buy, as well as trading at least 100 USDT in Spot. Successful completion of tasks provides participants with bonuses and lucky draw tickets, which serve as entries into weekly prize draws.

Each ticket grants one entry into the draws for the 90,000 USDT prize pool, distributed across the campaign period. Rewards will be delivered through Bybit’s Rewards Hub and can be claimed within 14 working days after the event concludes.

With this new initiative, Bybit continues to expand its offerings to meet the growing global demand for secure, user-friendly, and accessible crypto trading solutions.

The event is available exclusively to newly registered users who meet eligibility criteria, including completion of Individual Identity Verification Level 1 or Business Verification. Certain restrictions apply, including participants residing in the European Economic Area and other regions listed on Bybit’s restricted countries page.

#Bybit / #CryptoArk 

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

MELBOURNE, Australia, Oct. 22, 2025 /PRNewswire/ — Ampace will take the stage at All Energy Australia 2025 (Booth GG123), unveiling its latest advances in battery technology and next-generation energy storage solutions. As a trusted energy innovator serving over 50 million customers across 30 countries and regions, Ampace continues to drive progress in reliability, sustainability and high-performance energy storage technology. With proven large-scale manufacturing capabilities and a zero-safety-incident record, the company empowers partners and industries worldwide to achieve a safer, smarter energy transition.

To better harness Australia’s abundant solar resources and stabilize the grid amid rapid renewable expansion, Ampace will present innovations that help Australian industries and households optimize solar use and accelerate their energy transition. At this year’s exhibition, the showcased products include commercial & industrial (C&I), residential (RESS), UPS, and portable power applications.

At the show, Ampace will highlight three pillars of its innovation: unparalleled battery longevity, system-level efficiency, and advanced safety technologies.

• Redefining Battery Longevity with the Kunlun Series

At the heart of Ampace’s innovation lies the Kunlun series battery cells, engineered for ultra-long lifespan and exceptional reliability. Capable of delivering up to 15,000 charge–discharge cycles—nearly twice the industry average—Kunlun batteries extend system lifespan up to 20 years. This advancement eliminates costly mid-life replacements and reduces total lifecycle electricity costs by up to 30%

• Reimagining Efficiency with the UniC AG256-125

Integrated with Kunlun cells, the UniC AG256-125 all-in-one system is purpose-built for commercial and industrial users seeking high performance with minimal maintenance. Its Zero Liquid Cooling and Zero Air Conditioning design cuts lifetime energy use and requires one maintenance check per year. Proven in large-scale deployment in Chile, the UniC system has helped customers save over USD 1.2 million annually, delivering both economic and environmental benefits.

• Pioneering Safety with Semi-Solid Technology

Ampace will showcase its mass-produced semi-solid-state LFP battery cells—engineered for outstanding safety, energy density, and operational stability from data centers to homes. Featuring 20% higher energy density and zero thermal runaway, the technology eliminates fire risk and enhances lifecycle reliability. It will be demonstrated in the PU200 and PR-S4 systems to be unveiled at the exhibition.

Join Ampace at All Energy Australia 2025 — and experience firsthand Ampace’s next-generation solutions driving the global energy transition.

Booth GG123
October 29-30
Melbourne Convention and Exhibition Centre (MCEC), Melbourne

Time to swap subjectivity for structured talent assessment

• 91% of HR and 88% of leaders use subjective performance ratings
• Just 45% of HR and 30% of leaders use psychometric assessments
• 67% of high potential (HiPo) employees say identification has a significant impact on career goals

GLENDALE, Calif., Oct. 22, 2025 /PRNewswire/ — New research from Talogy, a global leader in talent management, reveals a significant gap between organization’s commitment to high potential (HiPo) programs and their reliance on subjective identification methods, increasing the risk of bias and limiting predictive accuracy.

The global study, drawing on feedback from over 1,000 professionals as well as insights from expert consultants, found that while 70% of organizations use a customized definition of HiPo, the methods used often depend on subjective judgment rather than structured assessment.

The HiPo Paradox: relying on subjectivity and gut feeling

The research points to a reliance on less structured, perception-based approaches that can overlook objectivity, with 91% of HR professionals and 88% of leaders using performance ratings and manager recommendations to select HiPo talent. 

In addition, a large majority of HR (79%) and leaders (72%) rated their programs as effective, despite the study finding that evaluation is often limited to tracking promotions, rather than linking HiPo success to business outcomes. 

Just 45% of HR and 30% of business leaders currently use psychometric assessments, the most structured and validated method available to identify future leaders. 

“This is one of the most critical takeaways from our research,” said Dan Hughes, senior director of R&D at Talogy.

“Organizations are investing significant time and resources into HiPo programs, but are often using methods such as manager recommendations and performance ratings – which can be prone to subjectivity – to identify talent.

“While these approaches can provide valuable perspectives, they also highlight the need for more comprehensive and reliable identification — combining these existing methods with rigorous, science-based assessments to more accurately pinpoint high-potential talent who can be significant drivers of their organization’s future success.”

Building stronger, future-ready talent pipelines

With over 50% of HiPo employees reporting that being identified has increased their commitment to their employer, and 67% saying that their HiPo status has impacted their career goals, it’s clear that HiPo programs boost retention rates.

However, the study warns that this retention boost is quickly lost if development is inconsistent. While mentoring and coaching are common, cross-functional training and job shadowing are underused, with 83% of HR professionals stating mentoring as the most common, compared to just 38% reporting e-learning as their most used development method. 

Hughes continues: “To truly harness the boost in motivation that comes from being identified as HiPo, organizations must move beyond informal practices and implement structured, science-backed tools with meaningful development opportunities that ensure fair identification and support targeted development.”

“By closing this gap and putting engaging and impactful development programs in place alongside fair, predictive, and scalable assessment strategies, organizations can maximise the potential of their top talent and reap long-term benefits.”

Russ Becker, CEO at Talogy added: “In today’s work environment, shaped by; rapid change, evolving skill demands, and increasing role complexity, organizations are being challenged to do more with less and stay lean. That’s why high-potential programs are more important than ever for companies that want to stay ahead and build a workforce ready for the future.”

Conducted in 2025, the research employed three methods: 

• rapid evidence assessment of independent scientific literature
• surveys administered to international HR professionals, leaders and HiPo employees from a variety of industries and sectors
• focus groups with experts at Talogy operating in the HiPo space

By examining the topic from the different perspectives of HR, leadership and HiPo employees, the research provides a fully balanced and carefully considered insight into existing HiPo programmes.

Read the report: https://info.talogy.com/en-us/hipo-executive-summary

High Potential employee image

LOS ANGELES, Oct. 22, 2025 /PRNewswire/ — SiiPet, a brand dedicated to decoding pet behavior and well-being through pioneering AI technology, transforming subtle signs into precise health insights, announced on Oct. 20 the launch of LitterLens, the world’s first AI-powered health monitor designed specifically for feline litter box behavior. Now available on SiiPet’s official website and Amazon at a retail price of $129 USD, Litterlens enables cat owners to track their pets’ bathroom frequency, duration, and overall habits, helping them detect early health changes and care with confidence.

“Changes in litter box habits are often among the first signs of urinary or digestive issues, yet they can easily go unnoticed, especially in multi-cat homes,” said Brian Fu, founder of SiiPet. “With LitterLens, we make those hidden signals visible through accessible, AI-powered insights, helping cat parents take action early and protect their cats’ well-being.”

Smart Monitoring for Early Detection

LitterLens uses AI-driven analysis to monitor every litter box visit with precision, tracking frequency, duration, and stool conditions in real time. The CatSense+ detection system minimizes false alerts by accurately identifying each entry, ensuring users receive only relevant health insights. With instant in-app notifications, cat owners can act early to address potential urinary or digestive issues before they become serious.

Individualized Insights for Multi-Cat Homes

Powered by Pet ID+ technology, LitterLens distinguishes between multiple cats in a household through advanced visual recognition, allowing each pet’s data to be tracked and analyzed individually. This feature makes health monitoring more reliable for multi-cat families, where subtle changes are often difficult to notice.

Vet-Ready Records with Privacy Control

Through its PoopSnap function, LitterLens can automatically capture clear, time-stamped photos of irregular stools to support veterinary consultations and long-term health tracking. Data is stored securely in the SiiPet app, where owners can review each cat’s trends and share updates with family members or veterinarians. For peace of mind, the Privacy Mode allows users to disable the camera at any time, while CatSense+ activates recording only when necessary.

Designed for Simplicity and Everyday Use

LitterLens is also built for convenience and durability, with a universal mounting system that fits most litter boxes and an IP65 water-resistant design for easy cleaning. The device provides HD live video with a built-in night light, runs on both wired and wireless power, and offers up to one month of battery life per charge.

SiiPet is committed to making pet care more scientific, longer-lasting, and worry-free. As a global innovator in AI-driven pet health management, the brand aims to create tools that help pet owners understand their pets better, from tracking daily habits to spotting early signs of health issues. With products like the PawTrack Camera and newly launched LitterLens, SiiPet turns everyday moments into meaningful data, empowering people to care for their pets with confidence and build a stronger, more connected bond with pets as family.

For more information, please visit: www.siipet.com